Culturally Aware AET Non-Initiation Intervention
Public ClinicalTrials.gov record NCT05465408. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Addressing Non-Initiation of Recommended Adjuvant Endocrine Therapy With a Culturally Informed-Intervention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to examine the feasibility and acceptability of a brief, nurse-led intervention to support breast cancer survivors who have delayed initiation of hormonal therapy or who have concerns about starting hormonal therapy.
Study identification
- NCT ID
- NCT05465408
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 35 participants
Conditions and interventions
Interventions
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2022 (Actual)
- Primary completion
- Nov 20, 2024 (Actual)
- Completion
- Nov 20, 2024 (Actual)
- Last update posted
- Feb 24, 2026
2022 – 2024
United States locations
- U.S. sites
- 11
- U.S. states
- 2
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| Dana-Farber Cancer Institute at St Elizabeth's Medical Center | Brighton | Massachusetts | 02135 | — |
| Emerson Hospital/MGH Cancer Center | Concord | Massachusetts | 01742 | — |
| Mass General at North Shore Cancer Center | Danvers | Massachusetts | 01923 | — |
| Dana-Farber Brigham Cancer Center - Foxborough | Foxborough | Massachusetts | 02035 | — |
| Dana-Farber Cancer Institute - Merrimack Valley | Methuen | Massachusetts | 01844 | — |
| Dana-Farber Brigham Cancer Center at Milford Regional Medical Center | Milford | Massachusetts | 01757 | — |
| Mass General at Newton Wellesley Hospital | Newton | Massachusetts | 02462 | — |
| Dana-Farber Brigham Cancer Center with South Shore Hospital | Weymouth | Massachusetts | 02190 | — |
| Dana-Farber/New Hampshire Onoclogy-Hematology | Londonderry | New Hampshire | 03053 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05465408, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05465408 live on ClinicalTrials.gov.